The
key event of 2001 was the ending of Retail Price Maintenance
(RPM), which previously set fixed minimum prices on
a wide range of Over the Counter / Consumer Healthcare
(OTC) products. Chemists were wary of the prospect
of a price war for General Sales Licence (GSL) products
with the big grocery chains. RPM's demise had an impact
on value growth of OTC as grocery multiples did exactly
as chemists feared, reduced prices in key areas and
on leading products.
The result was slower than historic value growth in
2002 at only 1.5%. This is low compared to a CAGR of
4.8% between 1997-2002. Some products such as allergy
remedies felt the first impact from price reductions
in 2002, having earlier avoided the full effect due
to their short selling season which took place before
RPM disappeared. Antihistamines/allergy remedies saw
a decline of 7.7% in value, compared to growth in 2001
of over 17%. Smoking cessation was the strongest performer
in OTC showing growth in value terms of 15.3%.
In 2002, the Medicines Control Agency (MCA) announced significant changes to
the process for medicine reclassification, or switching. The new process is intended
to encourage more manufacturers to apply for their medicines to be sold OTC and
to decrease processing time for straightforward applications.
Pharmacy selling is currently in decline in terms
of field force numbers as the numbers of independent
retail pharmacies has declined. However, there is
political pressure to increase the availability of
OTC Medicines. In January 2003, deregulation of the
NHS system for dispensing prescriptions was announced.
This will allow any grocery outlet to dispense NHS
medications under the supervision of a pharmacist,
doing away with the previous contract system which
limited the number of NHS dispensing locations to
just over 12,000.
Field Sales Representatives call on independents
and small chains / buying groups, whereas Head Office
Based Key Account and National Account Managers will
sell to Major Wholesalers and National Pharmacy Accounts.